Brothers, Michael J.

Peter E. Broadbent III practices in the areas of Health Law and Complex Litigation. Mr. Broadbent is a member of the Health Law Section of the Virginia State Bar and serves on the Richmond Bar Association's Publications Committee.

As a member of the firm's Health Care Practice Group, Mr. Broadbent advises health care professionals and businesses on compliance with Virginia and federal health laws and regulations. Mr. Broadbent has assisted the firm's clients in various areas of health care law, including governmental compliance and regulatory investigations. Additionally, Mr. Broadbent has served as a guest lecturer to the Virginia Commonwealth University Graduate School of Pharmacy.

In the Complex Litigation Practice Group, Mr. Broadbent has worked on sophisticated litigation, including extensive antitrust work in the health care realm. Mr. Broadbent has devoted a significant portion of his practice to assisting in the In Re Brand Name Prescription Drugs Antitrust Litigation (MDL 997), a major federal antitrust action that has been described as "one of the largest antitrust cases in American history." Elzinga, Kenneth G., and David E. Mills. "The Brand Name Prescription Drugs Antitrust Litigation (1999)." In The Antitrust Revolution: Economics, Competition, and Policy, 4th edn., edited by John E. Kwoka, Jr. and Lawrence J. White, 302. New York: Oxford University Press, 2004.